New Company is Only in U. S. That Stores Frozen Immune Cells Giving Clients Options for Future Medical Treatments
BioBancUSA™ launches the nation's first revolutionary immune cell preservation center dedicated to providing 'bioinsurance' against disease. Several of the world's foremost physicians have developed the advanced technology to collect and store an individual's immune cells as insurance against future disease.
Monterey, CA (PRWEB) March 3, 2007
BioBancUSA™ launches the nation's first revolutionary immune cell preservation center dedicated to providing 'bioinsurance' against disease. Several of the world's foremost physicians have developed the advanced technology to collect and store an individual's immune cells as insurance against future disease. The International Scientific Advisory Board of BioBancUSA announced today the official launch of the company after receiving a biologics license from the State of California. The company's management team also announced they began storing their first clients in February.
Robert Hayner, President and CEO of BiobancUSA states, "We are pleased to offer this unique and exclusive service. The launching of BioBancUSA is a groundbreaking innovation that will allow families to store their white blood cells for future potential medical uses." According to Mr. Hayner, The process of storing white blood cells is relatively easy; in fact, he states that it is "similar to donating blood." A consultation appointment is set up with BioBancUSA personnel, either by phone or in person. Upon arrival to the laboratory, the entire process takes one hour from start-to-finish, with the blood collection itself taking approximately 15 minutes. The blood is tested for any infectious diseases and is stored in an airtight aluminum cassette and placed into a cryogenic tank. BioBancUSA is the exclusive U. S. licensee of the original patent for the collection, processing and cryopreservation technology of white blood cells, giving the assurance of both technical integrity and legal legitimacy.
BioBancUSA anticipates that the clinical applications for the use of stored, healthy immune cells will explode in the near future. Current research shows stored white cells could be used for cancer, autoimmune diseases and immune restoration. Numerous clinical trials are under way which use white blood cells as the basis of therapy. For example, a recent ground breaking report by the National Institutes of Health unveiled a new approach to attack metastatic melanoma cancer. Also, Baylor Medical Center completed clinical trials using immune cells to fight breast cancer. Other recent research using immune cell therapy includes prostate and gastric cancer and various other cancers.
"Storing healthy white blood cells give patients the opportunity for future options as the medical technology expands," states Robert Keller, M. D., Chief Medical Officer of BioBancUSA. "Without these stored immune cells, an individual may miss the opportunity for future treatments because these cells may be compromised as we age."
The company is led by an International Scientific Advisory Board headed by the world-renowned Dr. Charron, M. D., Ph. D. Dr. Charron states "white blood cell (WBC) transfusion may well impact health in the 21st century to the same extent as Red Blood Cell (RBC) transfusion did over the 20th century."
Hugh Wilson, M. D., Laboratory and Medical Director, says "BioBancUSA's patented process yields the highest immune cell viability when thawed for use in treatment. We use GE Healthcare's most advanced freezing and archiving system to ensure optimal results."
BioBancUSA is now accepting new clients to begin storing immune cells in anticipation for future therapies. For more information about BioBancUSA contact Suzanne Hambleton at 831.601.3581 or visit their website at www. biobancusa. com. Media kits can be obtained upon request and exclusive tours can be arranged to select members of the media.
# # #
